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Effect of anatomical variability in brain on transcranial magnetic
stimulation treatment
Abstract
Transcranial Magnetic Stimulation is a non-invasive clinical therapy used to treat depression and migraine,
and shows further promise as treatment for Parkinson’s disease, Alzheimer’s disease, and other neurological
disorders. However, it is yet unclear as to how anatomical differences may affect stimulation from this
treatment. We use finite element analysis to model and analyze the results of Transcranial Magnetic
Stimulation in various head models.A number of heterogeneous head models have been developed using MRI
data of real patients, including healthy individuals as well as patients of Parkinson’s disease. Simulations of
Transcranial Magnetic Stimulation performed on 22 anatomically different models highlight the differences in
induced stimulation. A standard Figure of 8 coil is used with frequency 2.5 kHz, placed 5 mm above the head.
We compare cortical stimulation, volume of brain tissue stimulated, specificity, and maximum E-field induced
in the brain for models ranging from ages 20 to 60. Results show that stimulation varies drastically between
patients of the same age and health status depending upon brain-scalp distance, which is not necessarily a
linear progression with age.
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Transcranial Magnetic Stimulation is a non-invasive clinical therapy used to treat
depression and migraine, and shows further promise as treatment for Parkinson’s dis-
ease, Alzheimer’s disease, and other neurological disorders. However, it is yet unclear
as to how anatomical differences may affect stimulation from this treatment. We use
finite element analysis to model and analyze the results of Transcranial Magnetic
Stimulation in various head models. A number of heterogeneous head models have
been developed using MRI data of real patients, including healthy individuals as well
as patients of Parkinson’s disease. Simulations of Transcranial Magnetic Stimulation
performed on 22 anatomically different models highlight the differences in induced
stimulation. A standard Figure of 8 coil is used with frequency 2.5 kHz, placed 5 mm
above the head. We compare cortical stimulation, volume of brain tissue stimulated,
specificity, and maximum E-field induced in the brain for models ranging from ages
20 to 60. Results show that stimulation varies drastically between patients of the same
age and health status depending upon brain-scalp distance, which is not necessarily
a linear progression with age. © 2017 Author(s). All article content, except where
otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/). [http://dx.doi.org/10.1063/1.4974981]
INTRODUCTION
Transcranial Magnetic Stimulation (TMS) uses external time-varying magnetic fields to induce
electric fields within the brain to downregulate or upregulate targeted brain tissue. Although TMS
is currently only FDA approved to treat depression and migraine, it is also a promising treatment
for certain symptoms of Parkinson’s disease (PD), Schizophrenia, Obsessive Compulsive disorder,
and other neurological conditions.1,2 We use data obtained from the Human Connectome Project
(HCP), a study sponsored by the National Institute of Health which gathered a large amount of
Magnetic Resonance Images (MRI) from real individuals.3 In previous studies, we have shown Tran-
scranial Magnetic Stimulation induced in models developed using data from the HCP.4 Here, we
introduce models of Parkinson’s patients created using data obtained from the Parkinson’s Progres-
sion Marker’s Initiative (PPMI), a project which collected MRI images of patients with Parkinson’s
disease.5 We created head models of PPMI patients with the goal of comparing effects of TMS on
healthy individuals and those with Parkinson’s disease. It is well known that the structure of the
brain in Parkinson’s patients can vary drastically, depending on disease progression, due to lesions
which form on white matter surface.6,7 Furthermore, it is well known that brain volume generally
decreases with age as the brain shrinks, but this fact is variable with genetics and lifestyle.8 We
arhadimani@vcu.edu
2158-3226/2017/7(5)/056711/5 7, 056711-1 © Author(s) 2017
 
056711-2 Syeda et al. AIP Advances 7, 056711 (2017)
assert that these structural difference may influence the stimulation of the brain during TMS. To
study these effects and draw relationships between brain structure and stimulation effects, we com-
pare results of TMS simulations on models of healthy individuals (henceforth referred to as HCP
models) and Parkinson’s patients (PPMI models) of varying ages. We also include the highly het-
erogeneous models known as Duke and Ella, developed by the IT’IS Foundation using MRI data
of healthy individuals. We compute maximum E-field (Emax) induced in the brain as well as total
volume and surface of the brain which receives stimulation as well as the specificity of the induced
E-field. We compare these effects for patients of varying ages and discuss the implications for brain
stimulation.
SETUP AND CALCULATIONS
Simulations include commercial TMS Figure-of-8 coil run using current of 5000 Amps at a
frequency of 2.5 kHz. The TMS coils are situated 5 mm above the surface of the head in each
case, as shown in Figure 1. To find optimum power required to stimulate each patient’s brain tissue,
clinicians find the motor cortex area of the brain and induce enough stimulation to obtain a vis-
ible motor reaction (twitching of the hand), and this is called the motor threshold (MT). 120%
of MT is then used as the stimulation parameter in the targeted region of the brain. To mimic
clinical TMS, we define our stimulation threshold as half of the maximum E-field induced in a
particular model, which is close to MT for a healthy individual. Because Emax in each model
varies, we also define an absolute stimulation threshold of 50 V/m for purposes of comparison.
Then, we analyze the amount of brain volume stimulated, surface stimulated, and specificity, a
measure of how focused the E-field diffusion is in the brain tissue. We compute specificity by divid-
ing volume stimulated by surface stimulated. We show the results of both nominal stimulation,
which varies for each model, as well as stimulation above the absolute threshold of 50 V/m, for
purposes of clarity and comparison. Surface stimulation and specificity do not include the Duke
and Ella models due to IT’IS licensing restrictions. Biot-Savart Law and Maxwell’s equations
are used to calculate H-field, B-field, and E-field induced in the tissues, similar to our previous
publications.9–11
RESULTS AND DISCUSSION
Figure 2 shows electric field induced in two HCP models and two PPMI models. We compare
the induced electric field by analyzing the number of cells which receive stimulation above the given
FIG. 1. E-field induced on surface of two HCP models (top) and two PPMI models (bottom).
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FIG. 2. Two models demonstrating orientation of TMS coils.
threshold, both throughout the brain (volume stimulated), and on the surface of the grey matter
(surface stimulated). Stimulation threshold is first taken as Emax/2 and then as 50 V/m, for separate
comparisons.
A significant cause of stimulation variability is the distance between the brain and the scalp,
which increases with age. It is unclear how Parkinson’s disease affects this process, as it is possible
that the disease may cause structural differences in brain tissue.6 Figure 3 shows how the brain-
scalp distance varies with age in our models. The trend is much clearer with the younger healthy
individuals than for Parkinson’s patients. For this reason, we will compare all parameters using
brain-scalp distance, rather than age, as the independent variable. Figure 4 shows the maximum
E-field values induced in all models as brain-scalp distance varies. It is clear that in general, as
the brain-scalp distance increases, a lower maximum E-field value is induced in the brain tissue, in
both HCP and PPMI models. Because Emax varies for each model, and our stimulation threshold
is generally dependent on Emax, it is important to also choose an unconditional threshold to deci-
pher any trends between stimulation and brain-scalp distance. We take this absolute threshold as
50 V/m, because each model receives at least that value of stimulation. When this absolute threshold
is used, we use the phrase “absolute stimulation”. Figure 5 shows volume and surface stimulation in
each model as a function of brain-scalp distance. Relationships are much more obvious in the plots
utilizing the absolute threshold of 50 V/m. It is shown that as the brain-scalp distance increases,
volume stimulation and surface stimulation both decrease, which is intuitive given that the mag-
netic field decays as 1/r3, and any increase in the distance between the brain and the coil would
reduce the induced E-field significantly. Furthermore, we calculate specificity (volume stimulated
divided by surface stimulated) as a function of distance (Fig 6(a)), as well as a function of Emax
FIG. 3. Brain-Scalp Distance as a function of age, with blue data points representing healthy individuals and red data points
indicating Parkinson’s patients.
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FIG. 4. Maximum E-field values induced in each model as a function of brain-scalp distance.
(Fig 6(b))
.
Specificity as a function of distance does not show much of a trend, once again due to
the variability of Emax in each model. For this reason, then, we consider specificity as a function
of Emax, and discover a clear monotonically increasing relationship which seems to differ between
HCP and PPMI models. Models with high maximum E-field values also receive higher specificity of
stimulation.
FIG. 5. Volume of brain tissue and grey matter surface stimulated as a function of brain-scalp distance. 5a and 5b show volume
stimulated, 5c and 5d show surface stimulated.
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FIG. 6. Specificity with varying brain-scalp distance (a) and Emax (b).
CONCLUSION
While the volume, surface, and specificity vary drastically with between models, we are able to
discern clear trends when we observe these same parameters using the constant stimulation threshold
of 50 V/m. While general trends have been observed in the past between the patient’s age and brain-
scalp distance, these trends can differ drastically between healthy individuals and Parkinson’s patients.
In PPMI models, the variability in brain-scalp distance was much greater than in the HCP models. This
may be due to the disease or to age, both of which can alter brain structure.6,7 Furthermore, maximum
induced E-field can vary between patients of the same age. As Emax increases, the specificity is
monotonically increasing for both HCP and PPMI models. From these data, it is clear that stimulation
effects can vary drastically between patients of similar age and health status. The causes for this
discrepancy may be numerous, but we can infer from our results that stimulation effects are more
far more dependent upon brain-scalp distance than upon age and health. This implies that in order to
accurately determine TMS parameters for a particular patient, it is crucial to determine the brain-scalp
distance using MRI.
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